组织工程技术复合修复兔口腔黏膜的实验研究

武欣, 祝威, 王苹, 等. 组织工程技术复合修复兔口腔黏膜的实验研究[J]. 临床耳鼻咽喉头颈外科杂志, 2016, 30(22): 1782-1784,1789. doi: 10.13201/j.issn.1001-1781.2016.22.009
引用本文: 武欣, 祝威, 王苹, 等. 组织工程技术复合修复兔口腔黏膜的实验研究[J]. 临床耳鼻咽喉头颈外科杂志, 2016, 30(22): 1782-1784,1789. doi: 10.13201/j.issn.1001-1781.2016.22.009
WU Xin, ZHU Wei, WANG Ping, et al. Repairmen of the rabbit’s oral mucosa by tissue engineering technology[J]. J Clin Otorhinolaryngol Head Neck Surg, 2016, 30(22): 1782-1784,1789. doi: 10.13201/j.issn.1001-1781.2016.22.009
Citation: WU Xin, ZHU Wei, WANG Ping, et al. Repairmen of the rabbit’s oral mucosa by tissue engineering technology[J]. J Clin Otorhinolaryngol Head Neck Surg, 2016, 30(22): 1782-1784,1789. doi: 10.13201/j.issn.1001-1781.2016.22.009

组织工程技术复合修复兔口腔黏膜的实验研究

详细信息
    通讯作者: 祝威,E-mail:zhuwei30000@163.com
  • 中图分类号: R392.2

Repairmen of the rabbit’s oral mucosa by tissue engineering technology

More Information
  • 目的:探讨骨髓间充质干细胞(BMMSCs)与左旋聚乳酸/丝素蛋白(PLLA/SF)支架复合物修复兔口腔黏膜的可行性,同时评估PLLA与SF以何种比例混合构建组织工程口腔黏膜支架最理想。方法:分离、培养并鉴定BMMSCs,将其置于PLLA与SF的质量配比为70∶30(P70S30)PLLA/SF支架上复合培养1周后观察细胞表型有无改变;观察BMMSCs与P70S30的PLLA/SF支架复合物的口腔黏膜移植1周后的结构变化;比较细胞与支架复合物组、单纯支架组、创面自然修复组的创面愈合率。结果:①PLLA/SF支架对BMMSCs的细胞表型无明显影响;②BMMSCs与P70S30的PLLA/SF支架复合物口腔黏膜移植1周后与创面的融合较好;③以PLLA与SF的质量配比为70∶30的复合物组愈合率最高,平均愈合率为94.8%,与创面自然修复组及单纯支架组比较差异有统计学意义(P<0.01)。结论:①BMMSCs与PLLA/SF支架复合物具有构建理想的组织工程口腔黏膜的潜力;②PLLA与SF的质量配比为70∶30时最利于口腔黏膜创面的愈合,构建理想的组织工程口腔黏膜的潜力最大。
  • 加载中
  • [1]

    SLOFF M, SIMAIOFORIDIS V, DE VRIES R, et al.Tissue engineering of the bladder-reality or myth. A systematic review[J].J Urol,2014,192:1035-1042.

    [2]

    YAO D, LIU H, FAN Y.Silk scaffolds for musculoskeletal tissue engineering[J].Exp Biol Med (Maywood),2016,241:238-245.

    [3]

    HOGAN M V, KAWAKAMI Y, MURAWSKI C D, et al.Tissue engineering of ligaments for reconstructive surgery[J]. Arthroscopy,2015,31:971-979.

    [4]

    SHAMLOO A, MOHAMMADALIHA N, MOHSENI M.Integrative utilization of microenvironments, biomaterials and computational techniques for advanced tissue engineering[J].J Biotechnol,2015,212:71-89.

    [5]

    LANGER R, VACANTI J.Advances in tissue engineering[J].J Pediatr Surg,2016,51:8-12.

    [6]

    PARK D, LIM J, PARK J Y,et al.Concise review:stem cell microenvironment on a chip:current technologiesfor tissue engineering and stem cell biology[J]. Stem Cells Transl Med,2015,4:1352-1368.

    [7]

    VAPNIARSKY N, ARZI B, HU J C, et al. Concise review:human dermis as an autologous source of stem cells for tissue engineering and regenerative medicine[J].Stem Cells Transl Med, 2015,4:1187-1198.

    [8]

    COSSON S, OTTE E A, HEZAVEH H, et al.Concise review:tailoring bioengineered scaffolds for stem cell applications intissue engineering and regenerative medicine[J]. Stem Cells Transl Med, 2015,4:156-164.

    [9]

    PASCHOS N K, BROWN W E, ESWARAMOORTHY R, et al.Advances in tissue engineering through stem cell-based co-culture[J]. J Tissue Eng Regen Med, 2015, 9:488-503.

    [10]

    ZHAO Y, WALDMAN S D, FLYNN L E.Multilineage co-culture of adipose-derived stem cells for tissue engineering[J].J Tissue Eng Regen Med,2015,9:826-837.

    [11]

    DANG P N, DWIVEDI N, PHILLIPS L M, et al. Controlled dual growth factor delivery from microparticles incorporated within human bone marrow-derived nesenchymal stem cell aggregates for enhanced bone tissue engineering via endochondral ossification[J].Stem Cells Transl Med,2016,5:206-217.

    [12]

    ABDUL RAHMAN R, MOHAMAD SUKRI N, MD NAZIR N,et al.The potential of 3-dimensional construct engineered from poly(lactic-co-glycolicacid)/fibrin hybrid scaffold seeded with bone marrow mesenchymal stem cellsfor in vitro cartilage tissue engineering[J].Tissue Cell,2015,47:420-430.

    [13]

    WANG P, LIU X, ZHAO L,et al.Bone tissue engineering via human induced pluripotent,umbilical cord andbone marrow mesenchymal stem cells in rat cranium[J].Acta Biomater,2015,18:236-248.

  • 加载中
计量
  • 文章访问数:  136
  • PDF下载数:  66
  • 施引文献:  0
出版历程
收稿日期:  2016-06-01

目录